Neuronal SNCA transcription during Lewy body formation
Misfolded α-synuclein (α-syn) is believed to contribute to neurodegeneration in Lewy body disease (LBD) based on considerable evidence including a gene-dosage effect observed in relation to point mutations and multiplication of SNCA in familial Parkinson’
Tomoya Kon +8 more
doaj +4 more sources
Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation [PDF]
BackgroundWe and others have described the neurodegenerative disorder caused by G51D SNCA mutation which shares characteristics of Parkinson’s disease (PD) and multiple system atrophy (MSA).
Quinn, Niall +75 more
core +11 more sources
Snca and Bdnf gene expression in the VTA and raphe nuclei of midbrain in chronically victorious and defeated male mice. [PDF]
BACKGROUND: Alpha-synuclein (α-Syn) is a small neuronal protein that has been found to be expressed throughout the brain. It has been shown that α-Syn regulates the homeostasis of monoamine neurotransmitters and is involved in various degenerative and ...
Natalia N Kudryavtseva +3 more
doaj +3 more sources
SNCA 3′ UTR Genetic Variants in Patients with Parkinson’s Disease [PDF]
The SNCA (Synuclein Alpha) gene represents a major risk gene for Parkinson’s disease (PD) and SNCA polymorphisms have been associated with the common sporadic form of PD.
Antonela Blažeković +5 more
core +7 more sources
SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex [PDF]
Antisense oligonucleotide (ASO) therapy for neurological disease has been successful in clinical settings and its potential has generated hope for Alzheimer’s disease (AD).
Jennifer L. Brown +14 more
doaj +2 more sources
Peripheral SNCA+ cells as a poor prognostic factor for nivolumab therapy in advanced gastric cancer
Background We previously demonstrated that immune cells expressing α-synuclein (SNCA) are dramatically increased in peripheral blood of patients with gastric cancer (GC), but rarely in healthy donors, and that blocking SNCA is significantly effective ...
Chie Kudo-Saito +14 more
doaj +2 more sources
Lack of epistatic interaction of SNCA with APOE in synucleinopathies [PDF]
Two recent studies suggested that the APOE ε4 haplotype was associated with increased α-synuclein pathology in cell and mouse models. Genetic variants in the SNCA region have strong association with Parkinson’s disease (PD), dementia with Lewy bodies ...
Asayesh, Farnaz +25 more
core +5 more sources
Interpreting Gene Expression Effects of Disease-Associated Variants: A Lesson from SNCA rs356168 [PDF]
The SNCA intronic single nucleotide polymorphism (SNP), rs356168, has been associated with Parkinson’s disease (PD) in large genome wide association studies (GWAS). Recently, the PD-risk allele, rs356168-G was shown to increase SNCA-mRNA expression using
Omolara-Chinue Glenn +7 more
doaj +2 more sources
Four Copies of SNCA Responsible for Autosomal Dominant Parkinson’s Disease in Two Italian Siblings [PDF]
Background. Parkinson’s disease (PD) is mostly characterized by alpha-synuclein (SNCA) aggregation and loss of nigrostriatal dopamine-containing neurons.
Rosangela Ferese +12 more
doaj +2 more sources
Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models [PDF]
Parkinson disease (PD) is a neurodegenerative disorder characterized by the abnormal intracellular accumulation of SNCA/α-synuclein. While the exact mechanisms underlying SNCA pathology are not fully understood, increasing evidence suggests the ...
Dejung, Mario +24 more
core +4 more sources

